Leukaemia fears halt gene therapy trials
More US gene therapy trials were suspended last week, after news that a second patient receiving treatment for a rare immune disease at the Necker Hospital in Paris is showing symptoms of leukaemia. The US Food and Drug Administration (FDA) had already halted three trials in October, after hearing that...